103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024
HB4101

 

Introduced 5/19/2023, by Rep. Cyril Nichols - Dave Vella - La Shawn K. Ford - Maurice A. West, II - Carol Ammons

 

SYNOPSIS AS INTRODUCED:
 
505 ILCS 89/30 new

    Amends the Industrial Hemp Act. Sets forth provisions concerning hemp extract for human consumption. Provides that hemp extract distributed or sold in violation of the provisions shall be considered adulterated or misbranded. Provides that each establishment distributing products consisting of or containing hemp extract intended for human consumption must be permitted as a hemp food establishment by the Department of Agriculture. Provides that hemp or hemp extract intended for ingestion must be manufactured by an approved source. Provides that hemp or hemp extract intended for inhalation must be manufactured by a source permitted to manufacture hemp or hemp extract intended for inhalation. Provides that hemp extract intended for human consumption may not be manufactured, processed, packaged, held, prepared, or sold under specified provisions. Provides that hemp extract intended for human consumption shall not contain a total delta-9 tetrahydrocannabinol concentration that exceeds 0.3%. Provides that products intended for human consumption shall be considered adulterated if contaminants are detected at levels greater than the limits listed in the provisions. Sets forth limits concerning contaminants prohibited in hemp cultivation or processing; residual solvent limits for ingestion or inhalation; metals limits; biological limits for ingestion or inhalation; mycotoxin limits; total combined yeast and mold limit; and cannabinoid limits. Sets forth provisions concerning hemp extracts labeling, disposal, and age limits. Provides that hemp or hemp extract products that do not meet the requirements of the provisions may not be sold in the State. Provides that violations of the provisions shall result in the imposition of stop-sale or stop-use orders, an administrative fine of up to $5,000 per violation, permit suspension, permit revocation, or any combination of those penalties. Provides that the sale of hemp extract intended for inhalation to persons under the age of 21 shall result in an administrative fine of $5,000 per occurrence. Defines terms. Makes other changes.


LRB103 32639 BMS 62306 b

 

 

A BILL FOR

 

HB4101LRB103 32639 BMS 62306 b

1    AN ACT concerning agriculture.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Industrial Hemp Act is amended by adding
5Section 30 as follows:
 
6    (505 ILCS 89/30 new)
7    Sec. 30. Hemp extract for human consumption.
8    (a) Definitions. As used in this Section:
9    "Approved source" means an establishment manufacturing
10products consisting of or containing hemp extract intended for
11ingestion that meets local, State, or federal regulatory food
12safety or health standards from the jurisdiction of origin.
13    "Batch" or "lot" means the hemp extract produced during a
14period of time under similar conditions and identified by a
15specific code that allows traceability.
16    "Expiration date" means the month and year as determined
17by the manufacturer, packer, or distributor on the basis of
18tests or other information showing that the product, until
19that date, under the conditions of handling, storage,
20preparation, and use per label directions will, when consumed,
21contain not less than the quantity of each ingredient as set
22forth on its label.
23    "Hemp" means the plant Cannabis sativa L. and any part of

 

 

HB4101- 2 -LRB103 32639 BMS 62306 b

1that plant, including the seeds thereof, and all derivatives,
2extracts, cannabinoids, isomers, acids, salts, or isomers
3thereof, whether growing or not, that has a total delta-9
4tetrahydrocannabinol concentration that does not exceed 0.3%
5on a dry-weight basis.
6    "Hemp extract" means a substance of compound intended for
7ingestion that is derived from or contains hemp and that does
8not contain other controlled substances.
9    "Hemp food establishment" means an establishment as
10defined in extracting, manufacturing, processing, packing,
11holding, preparing, or selling hemp Extract intended for human
12consumption at wholesale or retail.
13    "Hemp extract intended for human consumption" includes
14products intended for human ingestion or human inhalation, but
15does not include topical applications.
16    "Ingestion" means the process of consuming hemp extract
17through the mouth, whether by swallowing into the
18gastrointestinal system or through tissue absorption.
19    "Inhalation" means the process of consuming hemp extract
20through the mouth or nasal passages into the respiratory
21system.
22    "Manufacturing" means preparing or packaging products
23consisting of or containing hemp extract intended for human
24consumption.
25    "Processor" or "extractor" means the establishment that
26removes the hemp extract oil from the hemp plant.

 

 

HB4101- 3 -LRB103 32639 BMS 62306 b

1    "Self-service merchandising" means an open display of hemp
2extract products to which the public has access without the
3intervention of the vendor or a store employee.
4    "Total delta-9 tetrahydrocannabinol concentration" means
5delta-9 tetrahydrocannabinol plus 0.877 x
6tetrahydrocannabinolic acid.
7    "Vending machine" means any self-service device that, upon
8completion of payment, dispenses hemp extract products without
9the necessity of replenishing the device between each
10operation.
11    (b) Hemp extract distributed or sold in violation of this
12Section shall be considered adulterated or misbranded. Hemp
13extract intended for human consumption that is not clearly
14labeled as intended for inhalation or ingestion must meet all
15of the requirements for hemp products intended for both
16inhalation and ingestion. If there are different requirements
17for hemp products intended for inhalation and hemp products
18intended for ingestion, the stricter standard shall apply.
19    (c) Each establishment distributing products consisting of
20or containing hemp extract intended for human consumption must
21be permitted as a hemp food establishment by the Department.
22The annual permit fee for a hemp food establishment is
23$650.00.
24    (d) Hemp or hemp extract intended for ingestion must be
25manufactured by an approved source. A hemp food establishment
26shall provide a valid hemp food establishment permit and the

 

 

HB4101- 4 -LRB103 32639 BMS 62306 b

1most recent food safety or health inspection report from the
2approved source to the Department upon request.
3    (e) Hemp or hemp extract intended for inhalation must be
4manufactured by a source permitted to manufacture hemp or hemp
5extract intended for inhalation. A hemp food establishment
6shall provide a valid hemp food establishment permit and the
7most recent inspection report from the permitting source to
8the Department upon request.
9    (f) Hemp extract intended for human consumption may not be
10manufactured, processed, packaged, held, prepared, or sold
11under Section 4 of the Food Handling Regulation Enforcement
12Act.
13    (g) Hemp extract intended for human consumption must be
14packaged in containers minimizing the exposure to light to
15prevent degradation of the cannabinoids. Containers used for
16hemp extract intended for human consumption must comply with
17this requirement.
18    (h) Hemp extract intended for human consumption shall not
19contain a total delta-9 tetrahydrocannabinol concentration
20that exceeds 0.3%.
21    (i) Hemp extract intended for human consumption shall not
22be manufactured, processed, packaged, held, or prepared in a
23private home or in a room used as living or sleeping quarters.
24    (j) Hemp extract intended for human consumption shall not
25be offered for sale by means of vending machines.
26    (k) Products intended for human consumption shall be

 

 

HB4101- 5 -LRB103 32639 BMS 62306 b

1considered adulterated if contaminants are detected at levels
2greater than the limits listed in this Section. Contaminant
3limits under this Section do not constitute authorization to
4use or apply any of the following contaminants during hemp
5cultivation or processing.
6        (1) The following substances are prohibited in Hemp
7    extract intended for inhalation:
8            (A) Abamectin, 300 parts per billion for
9        Ingestion; 100 parts per billion for Inhalation.
10            (B) Acephate, 3,000 parts per billion for
11        Ingestion; 100 parts per billion for Inhalation.
12            (C) Acequinocyl, 2,000 parts per billion for
13        Ingestion; 100 parts per billion for Inhalation.
14            (D) Acetamiprid, 3,000 parts per billion for
15        Ingestion; 100 parts per billion for Inhalation.
16            (E) Aldicarb, 100 parts per billion for Ingestion
17        or Inhalation.
18            (F) Azoxystrobin, 3,000 parts per billion for
19        Ingestion; 100 parts per billion for Inhalation.
20            (G) Bifenazate, 3,000 parts per billion for
21        Ingestion; 100 parts per billion for Inhalation.
22            (H) Bifenthrin, 500 parts per billion for
23        Ingestion; 100 parts per billion for Inhalation.
24            (I) Boscalid, 3,000 parts per billion for
25        Ingestion; 100 parts per billion for Inhalation.
26            (J) Captan, 3,000 parts per billion for Ingestion;

 

 

HB4101- 6 -LRB103 32639 BMS 62306 b

1        700 parts per billion for Inhalation.
2            (K) Carbaryl, 500 parts per billion for Ingestion;
3        500 parts per billion for Inhalation.
4            (L) Carbofuran, 100 parts per billion for
5        Ingestion or Inhalation.
6            (M) Chlorantraniliprole, 3,000 parts per billion
7        for Ingestion; 1,000 parts per billion for Inhalation.
8            (N) Chlordane, 100 parts per billion for Ingestion
9        or Inhalation.
10            (O) Chlorfenapyr, 100 parts per billion for
11        Ingestion or Inhalation.
12            (P) Chlormequat chloride, 3,000 parts per billion
13        for Ingestion; 1,000 parts per billion for Inhalation.
14            (Q) Chlorpyrifos, 100 parts per billion for
15        Ingestion or Inhalation.
16            (R) Clofentezine, 500 parts per billion for
17        Ingestion; 200 parts per billion for Inhalation.
18            (S) Coumaphos, 100 parts per billion for Ingestion
19        or Inhalation.
20            (T) Cyfluthrin, 1,000 parts per billion for
21        Ingestion; 500 parts per billion for Inhalation.
22            (U) Cypermethrin, 1,000 parts per billion for
23        Ingestion; 500 parts per billion for Inhalation.
24            (V) Daminozide, 100 parts per billion for
25        Ingestion or Inhalation.
26            (W) DDVP (Dichlorvos), 100 parts per billion for

 

 

HB4101- 7 -LRB103 32639 BMS 62306 b

1        Ingestion or Inhalation.
2            (X) Diazinon, 200 parts per billion for Ingestion;
3        100 parts per billion for Inhalation.
4            (Y) Dimethoate, 100 parts per billion for
5        Ingestion or Inhalation.
6            (Z) Dimethomorph, 3,000 parts per billion for
7        Ingestion; 200 parts per billion for Inhalation.
8            (AA) Ethoprop(hos), 100 parts per billion for
9        Ingestion or Inhalation.
10            (BB) Etofenprox, 100 parts per billion for
11        Ingestion or Inhalation.
12            (CC) Etoxazole, 1,500 parts per billion for
13        Ingestion; 100 parts per billion for Inhalation.
14            (DD) Fenhexamid, 3,000 parts per billion for
15        Ingestion; 100 parts per billion for Inhalation.
16            (EE) Fenoxycarb, 100 parts per billion for
17        Ingestion or Inhalation.
18            (FF) Fenpyroximate, 2,000 parts per billion for
19        Ingestion; 100 parts per billion for Inhalation.
20            (GG) Fipronil, 100 parts per billion for Ingestion
21        or Inhalation.
22            (HH) Flonicamid, 2,000 parts per billion for
23        Ingestion; 100 parts per billion for Inhalation.
24            (II) Fludioxonil, 3,000 parts per billion for
25        Ingestion; 100 parts per billion for Inhalation.
26            (JJ) Hexythiazox, 2,000 parts per billion for

 

 

HB4101- 8 -LRB103 32639 BMS 62306 b

1        Ingestion; 100 parts per billion for Inhalation.
2            (KK) Imazalil, 100 parts per billion for Ingestion
3        or Inhalation.
4            (LL) Imidacloprid, 3,000 parts per billion for
5        Ingestion; 400 parts per billion for Inhalation.
6            (MM) Kresoxim-methyl, 1,000 parts per billion for
7        Ingestion; 100 parts per billion for Inhalation.
8            (NN) Malathion, 2,000 parts per billion for
9        Ingestion; 200 parts per billion for Inhalation.
10            (OO) Metalaxyl, 3,000 parts per billion for
11        Ingestion; 100 parts per billion for Inhalation.
12            (PP) Methiocarb, 100 parts per billion for
13        Ingestion or Inhalation.
14            (QQ) Methomyl, 100 parts per billion for Ingestion
15        or Inhalation.
16            (RR) Methyl parathion, 100 parts per billion for
17        Ingestion or Inhalation.
18            (SS) Mevinphos, 100 parts per billion for
19        Ingestion or Inhalation.
20            (TT) Myclobutanil, 3,000 parts per billion for
21        Ingestion; prohibited at any concentration for
22        Inhalation.
23            (UU) Naled, 500 parts per billion for Ingestion;
24        250 parts per billion for Inhalation.
25            (VV) Oxamyl, 500 parts per billion for Ingestion
26        or Inhalation.

 

 

HB4101- 9 -LRB103 32639 BMS 62306 b

1            (WW) Paclobutrazol, 100 parts per billion for
2        Ingestion or Inhalation.
3            (XX) Pentachloronitrobenzene, 200 parts per
4        billion for Ingestion; 150 parts per billion for
5        Inhalation.
6            (YY) Permethrin, 1,000 parts per billion for
7        Ingestion; 100 parts per billion for Inhalation.
8            (ZZ) Phosmet, 200 parts per billion for Ingestion;
9        100 parts per billion for Inhalation.
10            (AAA) Piperonyl butoxide, 3,000 parts per billion
11        for Ingestion or Inhalation.
12            (BBB) Prallethrin, 400 parts per billion for
13        Ingestion; 100 parts per billion for Inhalation.
14            (CCC) Propiconazole, 1,000 parts per billion for
15        Ingestion; 100 parts per billion for Inhalation.
16            (DDD) Propoxur, 100 parts per billion for
17        Ingestion or Inhalation.
18            (EEE) Pyrethrins, 1,000 parts per billion for
19        Ingestion; 500 parts per billion for Inhalation.
20            (FFF) Pyridaben, 3,000 parts per billion for
21        Ingestion; 200 parts per billion for Inhalation.
22            (GGG) Spinetoram, 3,000 parts per billion for
23        Ingestion; 200 parts per billion for Inhalation.
24            (HHH) Spinosad A & D, 3,000 parts per billion for
25        Ingestion; 100 parts per billion for Inhalation.
26            (III) Spiromesifen, 3,000 parts per billion for

 

 

HB4101- 10 -LRB103 32639 BMS 62306 b

1        Ingestion; 100 parts per billion for Inhalation.
2            (JJJ) Spirotetramat, 3,000 parts per billion for
3        Ingestion; 100 parts per billion for Inhalation.
4            (KKK) Spiroxamine, 100 parts per billion for
5        Ingestion or Inhalation.
6            (LLL) Tebuconazole, 1,000 parts per billion for
7        Ingestion; 100 parts per billion for Inhalation.
8            (MMM) Thiacloprid, 100 parts per billion for
9        Ingestion; 100 parts per billion for Inhalation.
10            (NNN) Thiamethoxam, 1,000 parts per billion for
11        Ingestion; 500 parts per billion for Inhalation.
12            (OOO) Trifloxystrobin, 3,000 parts per billion for
13        Ingestion; 100 parts per billion for Inhalation.
14        (3) Residual solvent limits for ingestion or
15    inhalation:
16            (A) 1,2-Dichloroethane, 2 parts per million.
17            (B) 1,1-Dichloroethene, 8 parts per million.
18            (C) Acetone, 750 parts per million.
19            (D) Acetonitrile, 60 parts per million.
20            (E) Benzene, 1 part per million.
21            (F) Butane, 5,000 parts per million.
22            (G) Chloroform, 2 parts per million.
23            (H) Ethanol, 5,000 parts per million.
24            (I) Ethyl Acetate, 400 parts per million.
25            (J) Ethyl Ether, 500 parts per million.
26            (K) Ethylene Oxide, 5 parts per million.

 

 

HB4101- 11 -LRB103 32639 BMS 62306 b

1            (L) Heptane, 5,000 parts per million.
2            (M) Hexane, 250 parts per million.
3            (N) Isopropyl Alcohol, 500 parts per million.
4            (O) Methanol, 250 parts per million.
5            (P) Methylene Chloride, 125 parts per million.
6            (Q) Pentane, 750 parts per million.
7            (R) Propane, 5,000 parts per million.
8            (S) Toluene, 150 parts per million.
9            (T) Trichloroethylene 25 parts per million.
10            (U) Xylenes, Total (ortho-, meta-, para-), 150
11        parts per million.
12        (4) Metals limits:
13            (A) Cadmium, 500 parts per billion for ingestion;
14        200 parts per billion for inhalation.
15            (B) Lead, 500 parts per billion for ingestion or
16        inhalation.
17            (C) Arsenic, 1,500 parts per billion for
18        ingestion; 200 parts per billion for inhalation.
19            (D) Mercury, 3,000 parts per billion for
20        ingestion; 200 parts per billion for inhalation.
21        (5) Biological limits for ingestion or inhalation:
22            (A) Shiga toxin-producing Escherichia coli (STEC
23        E. coli) and other pathogenic E. coli, 1 CFU per gram.
24            (B) Salmonella, 1 CFU per gram.
25            (C) Aspergillus niger, Aspergillus fumigatus,
26        Aspergillus flavus, Aspergillus terreus, 1 CFU per

 

 

HB4101- 12 -LRB103 32639 BMS 62306 b

1        gram.
2        (6) Mycotoxin limits:
3            (A) Total Aflatoxin (B1, B2, G1, G2), 20 parts per
4        billion for ingestion or inhalation.
5            (B) Ochratoxin, 20 parts per billion for ingestion
6        or inhalation.
7        (7) Total combined yeast and mold limit: 100,000 CFU
8    per gram for ingestion or inhalation.
9        (8) Cannabinoid limits: total delta-9
10    tetrahydrocannabinol concentration shall not exceed 0.3%.
11        (9) If a testing sample is found to contain levels of
12    any pathogen, toxicant, residual solvent, metal, or
13    pesticide not enumerated in this Section or by State law,
14    then the hemp extract shall be considered adulterated.
15        (10) Devices used during the inhalation process must
16    not introduce contaminants over the limits listed in this
17    Section into the hemp extract product.
18    (l) Hemp extract intended for human consumption must be
19labeled as follows:
20            (1) If cannabinoids are marketed, the number of
21        milligrams of each cannabinoid per serving and the
22        serving size must be declared on the label.
23            (2) The label and advertisement shall not contain
24        claims indicating the product is intended for
25        diagnosis, cure, mitigation, treatment, or prevention
26        of disease; and if such claims are included, then the

 

 

HB4101- 13 -LRB103 32639 BMS 62306 b

1        product shall be considered misbranded.
2            (3) Hemp extract intended solely for inhalation
3        must be clearly labeled with the statement, "Not
4        Intended For Ingestion Do Not Eat.".
5    (m) Disposal.
6            (1) Laboratory samples found to contain more than
7        a total delta-9 tetrahydrocannabinol concentration of
8        0.3% shall be disposed of.
9            (2) Hemp extract intended for human consumption
10        containing a total delta-9 tetrahydrocannabinol
11        concentration that exceeds 0.3% shall be detained.
12        Hemp extract intended for human consumption containing
13        a total delta-9 tetrahydrocannabinol concentration
14        that exceeds 0.3% that has been detained shall not be
15        further subdivided or renumbered such that the
16        integrity of the lot is not maintained. The
17        establishment shall not dispose of the hemp extract
18        intended for human consumption in any manner until
19        written permission is given by the Department or a
20        court of competent jurisdiction.
21            (3) Upon receipt of written permission by the
22        Department or a court of competent jurisdiction, the
23        hemp extract intended for human consumption shall be
24        disposed of in a manner approved by a court of
25        competent jurisdiction.
26    (n) Age limit for hemp extract intended for inhalation.

 

 

HB4101- 14 -LRB103 32639 BMS 62306 b

1            (1) Any retailer that sells hemp extract intended
2        for inhalation shall post a clear and conspicuous sign
3        directly adjacent to the display of the product that
4        states the following: "THE SALE OF HEMP EXTRACT
5        INTENDED FOR INHALATION TO PERSONS UNDER THE AGE OF 21
6        IS PROHIBITED. PROOF OF AGE IS REQUIRED FOR
7        PURCHASE.".
8            (2) Hemp extract intended for inhalation may not
9        be mailed, shipped, or otherwise delivered to a
10        purchaser unless, before the delivery to the
11        purchaser, the hemp food establishment obtains
12        confirmation that the purchaser is 21 years of age or
13        older.
14            (3) Hemp food establishments shall require proof
15        of age from a purchaser of any product containing hemp
16        extract intended for inhalation before selling the
17        product to that person. Hemp food establishments shall
18        exercise diligence in the management and supervision
19        of their premises and in the supervision and training
20        of their employees to prevent the underage sale of
21        these products.
22            (4) Hemp extract intended for inhalation shall not
23        be offered for sale by means of self-service
24        merchandising unless proof of age has been verified
25        before allowing access to the self-service
26        merchandising.

 

 

HB4101- 15 -LRB103 32639 BMS 62306 b

1            (5) The giving or sampling of hemp extract
2        intended for inhalation products by a hemp food
3        establishment to any person under the age of 21 is
4        prohibited.
5    (o) Penalties.
6            (1) Hemp or hemp extract products must meet the
7        requirements of this Section. Hemp or hemp extract
8        products that do not meet the requirements of this
9        Section or without the documentation required in this
10        Section may not be sold in this State.
11            (2) Violations of this Section shall result in the
12        imposition of stop-sale or stop-use orders, an
13        administrative fine of up to $5,000 per violation,
14        permit suspension, permit revocation, or any
15        combination of those penalties.
16            (3) The sale of hemp extract intended for
17        inhalation to persons under the age of 21 shall result
18        in an administrative fine of $5,000 per occurrence.